Abstract
Background: Certain patients with locally advanced melanoma have a high risk of regional recurrence after surgical excision and lymphadenectomy alone. Growing evidence suggests that radiation therapy may improve local control with acceptable morbidity for patients with melanoma in some sites. There is no information regarding the safety or efficacy of this treatment when applied to the axilla for regional metastasis of cutaneous melanoma.
Methods: We conducted a retrospective evaluation of patients who received postoperative radiation therapy to the axillary lymphatics for malignant melanoma at the M. D. Anderson Cancer Center between 1980 and 1992. Twenty-eight patients were identified who had undergone a formal axillary lymph node dissection followed by postoperative irradiation to the full axilla and supraclavicular fossa. Twenty-two patients were irradiated using a hypofractionated treatment regimen (4–7 Gy/fraction), generally to 30 Gy in five fractions.
Results: Sixteen patients are currently alive. Actuarial survival at 5 years is 50.1%. Local tumor recurred or persisted in five patients, four of whom had clinically palpable tumor when they were irradiated.
Conclusions: Postoperative irradiation of the axilla for malignant melanoma has acceptable toxicity, even in those with extensive axillary dissection. In this group, patients treated for subclinical disease had a low rate of recurrence (1 of 21, [5%]).
Similar content being viewed by others
References
Dancuart F, Harwood AR, Fitzpatrick PJ. The radiotherapy of lentigo maligna and lentigo maligna melanoma of the head and neck.Cancer 1980;45:2279–83.
Harwood AR. Conventional radiotherapy in the treatment of lentigo maligna and lentigo maligna melanoma.J Am Acad Dermatol 1982;6:310–6.
Hellriegel W. Indications for and results of percutaneous radiotherapy of malignant melanoma.Strahlentherapie 1975;149:1–20.
Weitzel G. Radiotherapy of melanoma.Schweiz Med Wochenschr 1970;100:982–7.
Hornsey S. The radiation response of human malignant melanoma cells in vitro and in vivo.Cancer Res 1972;32:650–1.
Hornsey S. The radiosensitivity of melanoma cells in culture.Br J Radiol 1972;45:158.
Doss LL, Memula N. The radioresponsiveness of melanoma.Int J Radiat Oncol Biol Phys 1982;8:1131–4.
Trott KR, Kummermehr J, Hug O, Lukacs S, Braun FO. Radiation sensitivity of the amelanotic hamster melanoma in vitro and in vivo [Author's transl.].Strahlentherapie 1978;154:571–7.
Bentzen SM, Overgaard J, Thames HD, Overgaard M, Vejby HP, von der Maase H, Meder J. Clinical radiobiology of malignant melanoma.Radiother Oncol 1989;16:169–82.
Singletary SE, Shallenberger R, Guinee VF, McBride CM. Melanoma with metastasis to regional axillary or inguinal lymph nodes: prognostic factors and results of surgical treatment in 714 patients.South Med J 1988;81:5–9.
Rounsaville MC, Cantril ST, Fontanesi J, Vaeth JM, Green JP. Radiotherapy in the management of cutaneous melanoma: effect of time, dose, and fractionation.Front Radiat Ther Oncol 1988;22:62–78.
Habermalz HJ, Fischer JJ. Radiation therapy of malignant melanoma: experience with high individual treatment doses.Cancer 1976;38:2258–62.
Katz HR. The results of different fractionation schemes in the palliative irradiation of metastatic melanoma.Int J Radiat Oncol Biol Phys 1981;7:907–11.
Trott KR. The optimal radiation dose per fraction for the treatment of malignant melanomas [Editorial].Int J Radiat Oncol Biol Phys 1991;20:905–7.
Overgaard J, von der Maase H, Overgaard M. A randomized study comparing two high-dose per fraction radiation schedules in recurrent or metastatic malignant melanoma.Int J Radiat Oncol Biol Phys 1985;11:1837–9.
Ang KK, Byers RM, Peters LJ, Maor MH, Wendt CD, Morrison WH, Hussey DH, et al. Regional radiotherapy as adjuvant treatment for head and neck malignant melanoma. Preliminary results.Arch Otolaryngol Head Neck Surg 1990;116:169–72.
Johanson CR, Harwood AR, Cummings BJ, Quirt I. 0-7-21 radiotherapy in nodular melanoma.Cancer 1983;51:226–32.
Harwood AR, Lawson VG. Radiation therapy for melanomas of the head and neck.Head Neck Surg 1982;4:468–74.
Lee YT. Loco-regional recurrent melanoma: I. Natural history.Cancer Treat Rev 1980;7:59–72.
Cascinelli N, Preda F, Vaglini M, et al. Metastatic spread of stage I melanoma of the skin.Tumori 1983;69:449–54.
Byers RM. The role of modified neck dissection in the treatment of cutaneous melanoma of the head and neck.Arch Surg 1986;121:1338–41.
Cascinelli N, Bufalino R, Marolda R, et al. Regional non-nodal metastases of cutaneous melanoma.Eur J Surg Oncol 1986;12:175–80.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Strom, E.A., Ross, M.I. Adjuvant radiation therapy after axillary lymphadenectomy for metastatic melanoma: Toxicity and local control. Annals of Surgical Oncology 2, 445–449 (1995). https://doi.org/10.1007/BF02306379
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02306379